700 patients109,892 observations180 daysLIVE
eligible for SC-12 · confidence ≥ 70%

Patients needing attention

Synthetic demo data
Clear
54
patients · eligible for SC-12 · confidence ≥ 70%
Most common reason
GI intolerance
Most effective previous action
GI-04
Nutritional protocol
Estimated addressable population
26
eligible for GI-04, confidence ≥ 70%
Predicted persistence gain
+17%
LLIFE OS insight · why this cohort goes where it goes
grounded · add an LLM key for prose

eligible for SC-12 · confidence ≥ 70%: 54 patients, mean day 161. 22% have deteriorating tolerance, 91% unstable GI, 98% carry ≥60% discontinuation risk; mean GI 66, adherence 50%. Dominant clusters: EC-03 85%, LT 15%.

Shared biology: Cluster EC-03 (high response / high intolerance) 85%, Low butyrate capacity 76%, Low microbial diversity 76%, Adherence < 60% 76%, FUT2 non-secretor 74%, Baseline state S14 65%, IL6 high-expression variant 56%. Dietary detractors: fat in 94%, ultraProcessed in 83%, simpleCarbs in 74%.

What worked: NP-02 improved 61% of 23; what did not: GI-04 improved only 38% of 21. By biology: NP-02 works best in FUT2 non-secretor (75%) and worst in Low butyrate capacity (47%); GI-04 works best in IL6 high-expression variant (50%) and worst in Low butyrate capacity (25%).

No learned rules apply yet; run learning after the first campaign results.

PatientDayBaselineGIToleranceGI scoreDiscontinuationCluster
P-02028172S16UnstableImproving7796%EC-03
P-02272168S14UnstableUnstable7696%EC-03
P-02524158S14UnstableImproving6696%EC-03
P-02534169S14UnstableDeteriorating7496%EC-03
P-02537170S14UnstableDeteriorating7096%EC-03
P-02541113S14UnstableStable6896%EC-03
P-02543178S05UnstableStable8696%EC-03
P-02557175S14UnstableStable7996%EC-03
P-0263792S14UnstableDeteriorating6196%EC-03
P-02638177S14UnstableUnstable7296%EC-03
P-02656168S14UnstableDeteriorating6596%EC-03
P-02667171S14UnstableStable7696%EC-03
P-02688178S14UnstableImproving6796%EC-03
P-02700173S14UnstableImproving6596%EC-03
P-02469169S14UnstableStable6695%EC-03
P-0230392S14UnstableFavorable5994%EC-03
P-02472112S14UnstableUnstable6094%EC-03
P-02538168S12UnstableDeteriorating7493%EC-03
P-02569180S14UnstableStable6593%EC-03
P-02586176S14UnstableStable6093%EC-03
P-02053178S01UnstableImproving7592%LT
P-02607170S09UnstableStable7692%EC-03
P-02626168S14UnstableImproving6092%EC-03
P-0267294S14UnstableDeteriorating6892%EC-03
P-02697171S14ImprovingStable5490%EC-03
P-02431179S10UnstableStable8489%EC-03
P-02550136S15UnstableImproving6088%EC-03
P-02654102S14UnstableStable6587%EC-03
P-02014168S14UnstableUnstable7086%EC-03
P-02107180S11UnstableStable6186%EC-03
P-02156155S14DeterioratingStable5584%EC-03
P-02202180S14UnstableStable6182%EC-03
P-02480140S14UnstableStable6882%EC-03
P-02211170S11UnstableStable6281%LT
P-02209168S14UnstableFavorable6780%EC-03
P-02262180S11UnstableDeteriorating7380%EC-03
P-02634105S14StableDeteriorating5280%EC-03
P-02475123S14UnstableImproving7079%EC-03
P-02245180S14UnstableDeteriorating5877%EC-03
P-02408172S14UnstableDeteriorating6277%EC-03
P-02170171S14UnstableImproving6576%EC-03
P-02568179S20UnstableImproving7276%LT
P-02415173S05UnstableUnstable6675%EC-03
P-02491170S14UnstableDeteriorating6375%EC-03
P-02234175S13UnstableImproving6972%EC-03
P-02239178S16UnstableStable6771%EC-03
P-02394153S14StableDeteriorating4969%EC-03
P-02162174S15UnstableUnstable6568%LT
P-02300176S20UnstableImproving6468%EC-03
P-02139177S02UnstableStable6467%LT
P-02113168S02UnstableImproving6466%LT
P-02271170S14UnstableImproving6165%LT
P-02008179S14StableStable4362%EC-03
P-02553151S11UnstableStable6358%LT